Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Dyskinesia, Medication-InducedParkinson's Disease
Interventions
DEVICE

tSMS

Transcranial static magnetic field stimulation (tSMS) is a non-invasive brain stimulation (NIBS) technique that decreases cortical excitability. Static magnetic fields suitable for tSMS are obtained with commercially available neodymium magnets. We will use a cylindrical neodymium magnet of 45 mm diameter and 30 mm of thickness, with a weight of 360 g (MAG45r; Neurek SL, Toledo, Spain), which will be applied with south polarity to the motor cortex, over the representational field of hand area contralateral to the more affected side of the body.

DEVICE

sham

A non-magnetic metal cylinder, with the same size, weight and appearance of the magnet, will be used for sham stimulation (MAG45s; Neurek SL, Toledo, Spain).

Trial Locations (1)

28938

CINAC, Hospital Universitario Puerta del Sur, Móstoles

All Listed Sponsors
collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

collaborator

Hospital Nacional de Parapléjicos de Toledo

OTHER

collaborator

Hospital San Carlos, Madrid

OTHER

lead

Fundación de investigación HM

OTHER

NCT02657681 - Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS) | Biotech Hunter | Biotech Hunter